Health care provider characteristics associated with anal cancer screening in an urban academic medical system in the United States
International Journal of STD & AIDS · 2025
DOI: 10.1177/09564624251369563 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Daniel J Gore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Anus Neoplasms, Early Detection of Cancer, Mass Screening, Practice Patterns, Physicians'. Die Arbeit nennt 36 Literaturangaben. Gefördert von: NIAID NIH HHS, American Sexually Transmitted Diseases Association, Harvard University Center for AIDS Research.
Abstract (Originalsprache)
Background
New guidelines recommend anal cancer screening for priority populations with increased likelihoods of anal cancer including people with a history of HIV, gynecologic cancers, condyloma acuminata, and solid organ transplantation. However, little is known about U.S.-based screening practices prior to these guidelines.
Methods
We examined outpatient clinical encounters between 01/01/2015 and 08/01/2022 and analyzed provider characteristics and screening behaviors in an urban medical system in Boston, U.S. We used chi-squared tests and logistic regression to identify provider factors associated with anal cancer screening.
Results
Of 1098 providers, 48.5% completed at least one screening, including 93.8% ( n = 75/80) of infectious disease (ID) providers, 54.6% ( n = 372/681) of primary care providers (PCPs), and 28.3% ( n = 41/145) of obstetrician/gynecologists (OBGYNs) ( p < 0.001). Annual screening of priority populations was most common among providers trained in high-resolution anoscopy (19.8%–27.9% screened), and less common among ID providers (4.4%–8.7%), PCPs (0.4%–1.4%), and OBGYNs (0.1%–0.8%). In multivariate analysis, providers treating proportionately more cisgender women (adjusted odds ratio [aOR] = 0.988; 95% confidence interval [CI] 0.982–0.995), more non-white patients (aOR = 0.984; 95% CI 0.976–0.992), or fewer people with HIV were less likely to be screeners.
Conclusions
Most providers caring for priority populations did not complete anal cancer screenings, and annual screening levels were low across disciplines. Strategies are needed to optimize anal cancer screening practices, particularly for patients who are HIV-negative, non-white, and cisgender women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Fenway Health, Boston, Massachusetts, USA.
ORCID-Profile: Daniel J Gore
Förderung
- NIAID NIH HHS
- American Sexually Transmitted Diseases Association
- Harvard University Center for AIDS Research
Zitieren
APA
Gore, D. J., O'Donoghue, A. L., Zerillo, J. A., Multani, A., & Krakower, D. (2025). Health care provider characteristics associated with anal cancer screening in an urban academic medical system in the United States. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251369563
Vancouver
Gore DJ, O'Donoghue AL, Zerillo JA, Multani A, Krakower D. Health care provider characteristics associated with anal cancer screening in an urban academic medical system in the United States. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251369563
BibTeX
@article{Gore2025,
author = {Gore, Daniel J and O'Donoghue, Ashley L and Zerillo, Jessica A and Multani, Ami and Krakower, Douglas},
title = {Health care provider characteristics associated with anal cancer screening in an urban academic medical system in the United States},
journal = {International Journal of STD & AIDS},
year = {2025},
doi = {10.1177/09564624251369563}
}
EUVIMED